The Patent Finder

Methods of Treating or Preventing Inflammation and Hypersensitivity with Oxidative Reductive Potential Water Solution

Sonoma Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,072,726Methods of Treating or Preventing Inflammation and Hypersensitivity with Oxidative Reductive Potential Water Solution
In force
 · Low confidence
UsedRemaining
Sonoma Pharmaceuticals, Inc.In forceLow confidence
US 9,782,434Methods of Treating or Preventing Inflammation and Hypersensitivity with Oxidative Reductive Potential Water Solution
In force
 · High confidence
Microsafe Group DMCCIn forceHigh confidence
Application 11/656,087Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution
Abandoned
Abandoned Jan 29, 2010
Sonoma Pharmaceuticals, Inc.AbandonedAbandoned Jan 29, 2010
Application 15/729,138Methods of Treating or Preventing Inflammation and Hypersensitivity with Oxidative Reductive Potential Water Solution
Abandoned
Abandoned Sep 9, 2019
Sonoma Pharmaceuticals, Inc.AbandonedAbandoned Sep 9, 2019
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Sonoma Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited